Add to ORKGThe recommended treatment for chronic infection with hepatitis C virus (HCV) is a combination of pegylated interferon (pegIFN) alfa and ribavirin (RBV). Treatment duration is determined by HCV genotype: in genotype 1 (G1) infection, treatment usually lasts for 48 weeks, whereas in genotypes 2 and 3 (G2, G3), therapy for 24 weeks has been found to have equivalent efficacy
BACKGROUND: Current guidelines recommend a duration of 24 weeks of treatment with pegylated interfer...
With pegylated interferon and ribavirin, more than half of all chronically-infected hepatitis C pati...
Hepatitis C virus (HCV) genotype 3 is responsible for 30.1% of chronic hepatitis C infection cases w...
The recommended treatment for chronic infection with hepatitis C virus (HCV) is a combination of peg...
Combination therapy with pegylated interferon alfa (PEG-IFN alfa) and the nucleoside analogue ribavi...
The combination of pegylated-interferon (PEG-IFN)/ribavirin is currently the standard of care antivi...
Tremendous progress has been made in developing effective therapies for hepatitis C. The process beg...
Pegylated interferon plus ribavirin is the standard treatment for chronic hepatitis C (HCV). Even if...
The treatment durations for hepatitis C are guided by the analysis of hepatitis C virus (HCV) RNA in...
Introduction. Standard treatment for patients with chronic hepatitis C genotype 1 (CHC G-1) infectio...
The treatment durations for hepatitis C are guided by the analysis of hepatitis C virus (HCV) RNA in...
The effectiveness of extending treatment duration as response guided therapy was previously reported...
Patients with chronic infection with hepatitis C virus (HCV) genotype 1 often need 48 weeks of pegin...
Current guidelines recommend that patients with genotype 2 (G2) and 3 (G3) chronic hepatitis C be tr...
Current guidelines recommend that patients with genotype 2 (G2) and 3 (G3) chronic hepatitis C be tr...
BACKGROUND: Current guidelines recommend a duration of 24 weeks of treatment with pegylated interfer...
With pegylated interferon and ribavirin, more than half of all chronically-infected hepatitis C pati...
Hepatitis C virus (HCV) genotype 3 is responsible for 30.1% of chronic hepatitis C infection cases w...
The recommended treatment for chronic infection with hepatitis C virus (HCV) is a combination of peg...
Combination therapy with pegylated interferon alfa (PEG-IFN alfa) and the nucleoside analogue ribavi...
The combination of pegylated-interferon (PEG-IFN)/ribavirin is currently the standard of care antivi...
Tremendous progress has been made in developing effective therapies for hepatitis C. The process beg...
Pegylated interferon plus ribavirin is the standard treatment for chronic hepatitis C (HCV). Even if...
The treatment durations for hepatitis C are guided by the analysis of hepatitis C virus (HCV) RNA in...
Introduction. Standard treatment for patients with chronic hepatitis C genotype 1 (CHC G-1) infectio...
The treatment durations for hepatitis C are guided by the analysis of hepatitis C virus (HCV) RNA in...
The effectiveness of extending treatment duration as response guided therapy was previously reported...
Patients with chronic infection with hepatitis C virus (HCV) genotype 1 often need 48 weeks of pegin...
Current guidelines recommend that patients with genotype 2 (G2) and 3 (G3) chronic hepatitis C be tr...
Current guidelines recommend that patients with genotype 2 (G2) and 3 (G3) chronic hepatitis C be tr...
BACKGROUND: Current guidelines recommend a duration of 24 weeks of treatment with pegylated interfer...
With pegylated interferon and ribavirin, more than half of all chronically-infected hepatitis C pati...
Hepatitis C virus (HCV) genotype 3 is responsible for 30.1% of chronic hepatitis C infection cases w...